Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
The deal would repeal a cost-control measure in “Obamacare” known as the Cadillac Tax, an unpopular levy on benefit-rich health insurance plans scheduled to take effect in 2022. That means Congress is upsetting the balance between expanding access and controlling costs that former President Barack Obama tried to strike in his signature law, said Kathleen Sebelius, who served as his health secretary. “President Obama thought it was very important to have additional access paid for,” said Sebelius. “This just takes a big step backwards.” The deal was reached in late stage negotiations between congressional leaders and Treasury Secretary Steven Mnuchin as part of a broader agreement to keep the government operating past this weekend. As part of the package, the Trump administration would be barred from using its rule-making authority to take certain actions that would destabilize the ACA’s health insurance markets. But it punts on the two biggest consumer health care issues this year: curbing prescription drug costs and ending surprise medical bills. Lawmakers will try again early next year — when another round of budget legislation is due. The Cadillac Tax was intended as a levy on the most generous plans, pegged at 40% of the value above a certain threshold. In 2022 that threshold would have been $11,200 for single coverage and $30,100 for a family plan, according to the nonpartisan Kaiser Family Foundation. One in five employers would have been affected. The tax was widely supported by economists and health policy experts, who argued it would help confront the problem of high U.S. health care spending. That’s because employers were expected to scale back their plans or shift costs to workers to avoid paying. Many employers and labor unions opposed it from the beginning. “It could have meant higher deductibles for employees or less choice,” said Cynthia Cox, who leads research on the Obama health law at the Kaiser Foundation. Repeal will “have a positive effect on a lot of people with health insurance coverage.” But critics said taxpayers will be on the hook for more debt, since repeal of the Cadillac tax and two other unpopular “Obamacare” levies is estimated to add about $400 billion to the federal deficit over 10 years. “The Cadillac tax may have resulted in some modest cost increases when it took effect, but what it was actually going to do is reduce health care costs, which would have raised wages,” said Marc Goldwein, of the nonpartisan Committee for a Responsible Federal Budget, which advocates for reining in the nation’s $1-trillion deficit. Here’s an overview of some of the other major health care components of the budget deal: — Also repeals the health law’s health insurance tax and its sales tax on medical devices. These taxes were intended to help pay for the cost of expanding coverage under the health law, which currently provides insurance to about 20 million people. Even without these taxes, most of the law’s financing stays in place. —Blocks the Trump administration from issuing regulations that would end the health law’s automatic re-enrollment provision, or from shutting down a state-level workaround called “silver loading,” which has helped stabilize “Obamacare”premiums. —Extends and increases Medicaid funding for U.S. territories, including Puerto Rico.

Ex Output:
Budget deal puts access to health care above curbing costs.


Ex Input:
In January, China approved imports of a new genetically modified soybean variety — Enlist E3 soybeans jointly made by Corteva Agriscience, a division of DowDupont and seed company MS Technologies — that can withstand the herbicide 2,4-D. “This is great news for U.S. soybean growers,” said Joseph Merschman, president of MS Technologies in a February press release. “This announcement clears the way for even more soybean growers to experience the high-yielding elite genetics and exceptional weed control offered by the Enlist E3 soybean system.” DowAgrosciences declined to comment for this story. ___ The nonprofit news outlet Midwest Center for Investigative Reporting provided this article to The Associated Press through a collaboration with Institute for Nonprofit News. ___ The herbicide — 2,4-D — was one of the active ingredients in Agent Orange and has been shown to drift miles away from where it’s applied. The U.S. used Agent Orange during the Vietnam War to eliminate crops and forest covers for enemy troops. The International Agency for Research on Cancer named the weed killer a possible human carcinogen. Studies have also linked 2,4-D to endocrine disruption, disturbing estrogen, androgen and thyroid hormones. Over the past two decades, a growing number of weeds have become resistant to glyphosate, the most popular weed killer in the world, sold as Monsanto’s Roundup. In response, agribusiness companies, like Dow and Monsanto, have introduced new genetically modified varieties of soybeans that can be sprayed with other herbicides that kill glyphosate-resistant weeds. The United States exports $14 billion worth of soybeans to China, or one of every four rows of soybeans, annually, according to the American Soybean Association, an organization of soybean producers. Trade tensions with China and higher import taxes on U.S. soybeans have thwarted imports recently. The U.S. Department of Agriculture has projected that increased 2,4-D use due to the Enlist system would likely increase the amount of the weed killer sprayed between 200 and 600 percent by 2020. Already, it’s one of the most commonly used herbicides in the United States, used in conventional agriculture including corn and is one of the most commonly used home and garden herbicides. In 2016, the USDA estimated that farmers used 44.4 million pounds of 2,4-D on crops across the U.S. “This is just going to absolutely be a disaster,” said Nathan Donley, a senior scientist at the Center for Biological Diversity, a nonprofit organization that works to protect endangered species. The Enlist approval gives farmers looking to manage glyphosate-resistant weeds a new tool at a time when the dominant soybean system — Monsanto’s Roundup Ready 2 Xtend soybeans — has caused widespread issues in the Midwest and South. Those soybeans are genetically engineered to withstand being sprayed by dicamba, a volatile herbicide that has drifted off target and damaged millions of acres of non-resistant soybeans, other crops and natural areas since the Environmental Protection Agency approved new versions of the weed killer for use on soybeans in November 2016. More than 90 percent of soybeans grown in the United States are genetically modified, but there are only three major systems that are commonly used to combat glyphosate-resistant weeds: Monsanto’s Xtend, DowDupont’s Enlist and BASF’s LibertyLink soybeans, which are resistant to glufosinate, another herbicide. Enlist soybeans can also be sprayed with glufosinate. The extent to which 2,4-d-resistant soybeans will be planted is unknown, largely because of the widespread market penetration by dicamba-resistant soybeans. Company officials estimated the product will have at least 10 percent market share by 2020, which would be about 9 million acres in the United States. In two years, dicamba went from being sprayed on zero acres of soybeans to more than 40 million acres. Aaron Hager, an associate professor at the University of Illinois, said many farmers have adopted Monsanto’s Xtend soybeans as a protection measure against drift from dicamba. “It’s going to be difficult for (Enlist) to gain market penetration partially because of how well entrenched dicamba already is,” Hager said. The main question for farmers considering Enlist is whether drift from dicamba will damage Enlist soybeans, said Charles Benbrook, a visiting professor at the University of Newcastle who has spent decades studying pesticides at various institutions. “One of the huge questions is, is there any cross resistance? Will they be any less vulnerable to damage from drifting dicamba and vice versa?” Benbrook said. Benbrook said they may be able to coexist. Though 2,4-D and dicamba are different pesticides, their similarities might allow some cross-resistance in genetically modified soybeans, Benbrook said. Both dicamba and 2,4-D have been used for decades on other crops but at a smaller scale. Both are broadleaf herbicides that kill plants in similar ways, mimicking natural plant hormones called auxins and causing abnormal growth. Like the new version of dicamba, the new 2,4-D strain approved for usage on soybeans is designed to be less volatile than past versions. If there is no cross-resistance, Benbrook projected that Corteva, a division of DowDupont, and Bayer, which owns Monsanto, will likely have to come up with a deal to put the resistant genes in both company’s systems, increasing the price for farmers. Donley said both herbicides, having similar modes of actions and a propensity to drift, will insert an element of doubt on what caused drift damage. States across the Midwest and South have received a record number of pesticide misuse complaints from farmers since dicamba was allowed on soybeans. Already, some scientists have speculated that 2,4-D is causing some of the alleged dicamba damage. “Industry is going to use this to say, ‘how do you know it’s our product?’” Donley said. “It’s going to enable the industry to do what they do best, which is sow doubt in the public.” Environmental groups argue the transition to 2,4-D-resistant soybeans, and the increased spraying that goes along with it, is indicative of the problems with industrial agriculture. Jennifer Sass, senior scientist at the Natural Resource Defense Council, an environmental advocacy group, has researched the human health effects of 2,4-D, and said that the herbicide can cause disruptions in the endocrine system. She said that the link to cancer isn’t quite as established. Though 2,4-D is considered a “possible carcinogen,” the research isn’t quite as strong, but that’s because of the difficulties in collecting data, she said. “Those are all data and red flags, but there’s so many reasons to get off this treadmill. Waiting for more confidence in the cancers means waiting for more farmers and pesticide applicators to get cancer, and I don’t think anyone wants to collect our data that way,” Sass said. In some places, some types of glyphosate-resistant weeds, like Palmer amaranth, are already becoming resistant to 2,4-D and dicamba. Bill Freese, a senior scientist at the Center for Food Safety, which is a nonprofit group focused on the environmental effects of food production, said, in addition to human health issues, more spraying will lead to environmental issues, like the killing of pollinators and wild plants, he said. Donley, at the Center for Biological Diversity, has documented those problems with glyphosate and dicamba, especially when it comes to monarch butterflies and milkweed. He said more spraying will lead to more resistance and new herbicides. “It’s a poor answer to a complex situation, and it’s going to be getting worse,” Donley said. “In five-to-10 years, we’re going to be looking for the next herbicide. History tells us what’s going to happen in this case. It’s kind of crazy we’re even considering going here.”

Ex Output:
Last year it was dicamba, this year it’s 2,4-D.


Ex Input:
Maryland lawmakers, state officials and union members gathered in Annapolis to address the shortage during a joint hearing before the Senate Budget and Taxation Committee and the House Appropriations Committee. Hogan Administration officials said during the hearing that they are aware of the safety concerns and are working to address them, along with the shortage. Jason Kramer, policy analyst with Legislative Services, said during the hearing that the Department of Public Safety and Correctional Services alone had a need for more than 1,000 employees, while agencies like the Department of Juvenile Services and Department of Health were short more than 200 positions each, according to the study. Delegate Marc Korman, D-Montgomery, noted during the hearing that recent safety incidents “triggered” the meeting Tuesday morning, which also included testimony from members of Maryland’s American Federation of State, County and Municipal Employees — a public employee trade union. The members, donning green union shirts, filled the seats in the hearing room. In a news conference held shortly before the hearing, Patrick Moran — the president of the union — spoke of what he described as “systematic underfunding and delays” in filling vacancies. He said the union is demanding “immediate action,” but also noted that the members present in Annapolis had “no confidence” in Gov. Larry Hogan as an employer. Mike Ricci, a spokesman for Hogan, said in a written statement that once the union, “agrees to the ground rules that require them to bargain in good faith — rules that other unions have agreed to year after year — our administration is ready and willing to move forward with negotiations.” Delegate Shelly Hettleman, D-Baltimore County, attended the news conference and said that state employees are “underpaid and overworked,” and the staffing shortages are “putting people in danger.” Jeremy Jeffers, a resident adviser with the Department of Juvenile Services, testified during the hearing and said he has personally dealt with the “dangers” of understaffing, noting that he has been assaulted “multiple times,” suffered six concussions and even lost part of his finger during an incident. “I would challenge anyone to come and spend a shift,” Jeffers said. Ikeia Cornish, a direct care assistant at Eastern Shore Hospital Center, also testified and said one of her coworkers was “blindsided” and beaten by one of the patients. She referred to staffing shortages as a “crisis,” which leads to “more staff and patient injuries” and an “unsecure environment” Representatives from the Hogan Administration also testified during the hearing and addressed what is being done to alleviate the staffing problem. David Brinkley, secretary of the Department of Budget and Management, said the administration takes the staffing shortage issue “very seriously” and is focused on “hard-to-fill” positions like correctional officers. Nick Pepersack, Brinkley’s deputy chief of staff, later confirmed to Capital News Service that those employees received a nearly 10% salary increase between January and July of this year. Total salary enhancements in the last and current fiscal years, Pepersack said, amounted to approximately $467 million for employees statewide. Robert Neall, secretary of the Department of Health, said there is now an “increase in emphasis” on reporting all incidents at state hospitals and he looks “forward to reporting more progress” in January. Delegate Kirill Reznik, D-Montgomery, addressed Neall during the hearing and said while he has “no doubt” that the secretary is trying, “we have been here before.” “Ever year we hear, ‘these are all the things we are doing’ . and every year, we come back here,” Reznik said. Pressed by Reznik on where the department will be in terms of vacancies next year, Neall repeated that he expects “significant” progress, but could not answer the question “with specificity.” Sen. Andrew Serafini, R-Washington, told Capital News Service after the hearing that with regard to the safety incidents, “we have a more violent community in general.” “It’s not that we don’t care” about state employees, Serafini said, adding that the characterization to the contrary is “problematic.” ___ This story was produced by the University of Maryland’s Capital News Service.

Ex Output:

MD lawmakers, officials, union meet on staffing shortages.